ES2181446T3 - Composicion sinergica para usar en el tratamiento del cancer. - Google Patents

Composicion sinergica para usar en el tratamiento del cancer.

Info

Publication number
ES2181446T3
ES2181446T3 ES99924999T ES99924999T ES2181446T3 ES 2181446 T3 ES2181446 T3 ES 2181446T3 ES 99924999 T ES99924999 T ES 99924999T ES 99924999 T ES99924999 T ES 99924999T ES 2181446 T3 ES2181446 T3 ES 2181446T3
Authority
ES
Spain
Prior art keywords
cancer
treatment
composition
synergic composition
inulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99924999T
Other languages
English (en)
Inventor
Henryk Taper
Anne Frippiat
Loo Jan Van
Marcel Roberfroid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tiense Suikerraffinaderij NV
Original Assignee
Tiense Suikerraffinaderij NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tiense Suikerraffinaderij NV filed Critical Tiense Suikerraffinaderij NV
Application granted granted Critical
Publication of ES2181446T3 publication Critical patent/ES2181446T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composición farmacéutica caracterizada porque comprende una combinación de una dosis efectiva de inulina y de un fármaco anticancerígeno antimetabólico.
ES99924999T 1998-05-18 1999-05-18 Composicion sinergica para usar en el tratamiento del cancer. Expired - Lifetime ES2181446T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98870113A EP0958825A1 (en) 1998-05-18 1998-05-18 Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer

Publications (1)

Publication Number Publication Date
ES2181446T3 true ES2181446T3 (es) 2003-02-16

Family

ID=8237043

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99924999T Expired - Lifetime ES2181446T3 (es) 1998-05-18 1999-05-18 Composicion sinergica para usar en el tratamiento del cancer.

Country Status (7)

Country Link
EP (2) EP0958825A1 (es)
AT (1) ATE225179T1 (es)
DE (1) DE69903283T2 (es)
DK (1) DK1079840T3 (es)
ES (1) ES2181446T3 (es)
PT (1) PT1079840E (es)
WO (1) WO1999059600A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1125507A1 (en) 2000-02-15 2001-08-22 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Inulin products with improved nutritional properties
EP1428528A1 (en) * 2002-09-27 2004-06-16 Tiense Suikerraffinaderij N.V. Synergistic combinations of dietary fiber and NSAIDs for the treatment of cancer
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
WO2006002106A2 (en) * 2004-06-22 2006-01-05 Pro-Pharmaceuticals, Inc. Compositions and methods for the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide
NZ706991A (en) 2010-03-29 2016-08-26 Ferring Bv A fast dissolving pharmaceutical composition
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
RU2633640C2 (ru) 2011-09-16 2017-10-16 Ферринг Б.В. Быстрорастворимая фармацевтическая композиция

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69520528T2 (de) * 1994-06-14 2001-09-27 Raffinerie Tirlemontoise, S.A. Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel

Also Published As

Publication number Publication date
ATE225179T1 (de) 2002-10-15
EP1079840B1 (en) 2002-10-02
EP1079840A1 (en) 2001-03-07
EP0958825A1 (en) 1999-11-24
PT1079840E (pt) 2002-12-31
DE69903283T2 (de) 2003-02-13
DK1079840T3 (da) 2002-11-04
DE69903283D1 (de) 2002-11-07
WO1999059600A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
BR0009647A (pt) Docetaxel em combinação com rhumab her2 para o tratamento de cânceres
BRPI0411171A (pt) derivados de carboidratos de rapamicina, composição farmacêutica, método para o tratamento de uma doença tratável por rapamicina e dispositivo médico
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
BR0008447A (pt) Métodos de tratamento de distúrbios mitocondriais
BR0312286A (pt) pró-medicamentos de 2' e 3' - nucleosìdeo modificado para tratamento de infecções por flaviviridae
BR0114310A (pt) Derivados do glicopiranosiloxibenzilbenzeno e composições medicinais contendo os mesmos
BR0208563A (pt) composições de n-acetilcisteìna e métodos para o tratamento e prevenção de toxidade de droga
EA200900626A1 (ru) Комбинированное лечение ингибиторами sglt-2 (натрийзависимый сопереносчик глюкозы 2) и содержащими их фармацевтическими композициями
BRPI0509927A (pt) composição farmacêutica, uso de uma composição de matéria, e, uso de uma combinação terapeuticamente eficaz de um oligonucleotìdeo anti-sentido de survivina e cloridrato de gemcitabina
BR0107147A (pt) Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações
BRPI0509139A (pt) composição, e, método de estimulação de uma resposta imune em um indivìduo, de tratamento profilático de uma doença, de melhoramento de um sinal ou sintoma associado com uma doença, de alvejamento de um tumor, de inibição do crescimento de tumor, e de detecção de um tumor
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
AR027355A1 (es) Acidos tiazolidincarboxilicos
BR0316170A (pt) Combinação, composição farmacêutica, uso de uma combinação, e, método para a profilaxia ou tratamento sinergìstico de câncer
DK1401458T3 (da) Sammensætning bestående af PHY906 og kemoterapeutiske midler
ES2181446T3 (es) Composicion sinergica para usar en el tratamiento del cancer.
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
BR0215935A (pt) Terapia combinada para tratamento de leucemia aguda e sìndrome mielodisplásica
UY27018A1 (es) Derivados de la pirimidina
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
CY1114686T1 (el) Χρηση toy ck2 αναστολεα για την θεραπεια και χημειοευαισθητοποιηση των ανθεκτικων σε αντικαρκινικα φαρμακα ογκων
SE0401871D0 (sv) New compositions
TNSN05065A1 (en) Use of prebiotics for the treatment and prevention of hyperglycaemic syndromes
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
DE60219963D1 (de) Pharmazeutische zusammensetzung zur kontrolle des blutzuckers bei patienten mit typ 2 diabetes